FIFTH AMENDMENT TO BUILD-TO-SUIT LEASERigel Pharmaceuticals Inc • March 6th, 2018 • Pharmaceutical preparations
This FIFTH AMENDMENT TO BUILD-TO-SUIT LEASE ("Fifth Amendment") is made and entered into as of July 24, 2017, by and between HCP BTC, LLC, a Delaware limited liability company ("Landlord"), and RIGEL PHARMACEUTICALS, INC., a Delaware corporation ("Tenant").
TRANSITION AND SEPARATION AGREEMENT AND GENERAL RELEASETransition and Separation Agreement and General Release • March 6th, 2018 • Rigel Pharmaceuticals Inc • Pharmaceutical preparations • California
This Transition and Separation Agreement and General Release (hereinafter, the “Agreement”) is made and entered into between Ryan Maynard (“Employee”) and Rigel Pharmaceuticals, Inc., its affiliated companies, subsidiaries, agents, attorneys, successors, assigns, and representatives (hereinafter collectively, the “Company”). The Company and Employee are collectively referred to herein as the “Parties.”
